Vidarabine, an anti-herpesvirus agent, prevents catecholamine-induced arrhythmias without adverse effect on heart function in mice

Vidarabine, an Anti-Herpes Virus Agent, Protects Against the Development of Heart Failure With Relatively Mild Side-Effects on Cardiac Function in a Canine Model of Pacing-Induced Dilated Cardiomyopathy

(2016) Takashi Nakamura et al.   CIRCULATION JOURNAL

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs

(2016) Takeshi Wada et al.   JOURNAL OF TOXICOLOGICAL SCIENCES

Alcohol Dehydrogenase Protects against Endoplasmic Reticulum Stress-Induced Myocardial Contractile Dysfunction via Attenuation of Oxidative Stress and Autophagy: Role of PTEN-Akt-mTOR Signaling

(2016) Jiaojiao Pang et al.   PLoS One

Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation

(2015) G. M. De Ferrari et al.   CIRCULATION

Mechanisms of Sudden Cardiac Death: Oxidants and Metabolism

(2015) K.-C. Yang et al.   CIRCULATION RESEARCH

Mitochondrial oxidative stress promotes atrial fibrillation

(2015) Wenjun Xie et al.   Scientific Reports

Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice

(2015) Kenji Suita et al.   PLoS One

Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation

(2014) David Y. Chiang et al.   CARDIOVASCULAR RESEARCH

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2014) Craig T. January et al.   CIRCULATION

Cardiac Mitochondria and Reactive Oxygen Species Generation

(2014) Yeong-Renn Chen et al.   CIRCULATION RESEARCH

Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses

(2014) Satoshi Okumura et al.   JOURNAL OF CLINICAL INVESTIGATION

CaMKII oxidative activation and the pathogenesis of cardiac disease

(2014) Elizabeth D. Luczak et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

‘Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption’

(2013) Mariana S. De Lorenzo et al.   AGING CELL

Type 5 Adenylyl Cyclase Increases Oxidative Stress by Transcriptional Regulation of Manganese Superoxide Dismutase via the SIRT1/FoxO3a Pathway

(2013) Lo Lai et al.   CIRCULATION

Oxidative Stress and Sarcomeric Proteins

(2013) Susan F. Steinberg   CIRCULATION RESEARCH

Adenylyl cyclase 6 deletion increases mortality during sustained β-adrenergic receptor stimulation

(2013) Tong Tang et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Prevention of heart failure in mice by an antiviral agent that inhibits type 5 cardiac adenylyl cyclase

(2012) Kosaku Iwatsubo et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Reactive oxygen species contribute to the development of arrhythmogenic Ca2+waves during β-adrenergic receptor stimulation in rabbit cardiomyocytes

(2012) Elisa Bovo et al.   JOURNAL OF PHYSIOLOGY-LONDON

Apoptosis in Heart Failure

(2011) Takayuki Fujita et al.   CIRCULATION JOURNAL

Inhibition of CaMKII Phosphorylation of RyR2 Prevents Induction of Atrial Fibrillation in FKBP12.6 Knockout Mice

(2011) Na Li et al.   CIRCULATION RESEARCH

Adenylyl Cyclase 6 Deletion Reduces Left Ventricular Hypertrophy, Dilation, Dysfunction, and Fibrosis in Pressure-Overloaded Female Mice

(2010) Tong Tang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation

(2009) Eleni Bassiakou et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Electrical stimulation of human embryonic stem cells: Cardiac differentiation and the generation of reactive oxygen species

(2009) Elena Serena et al.   EXPERIMENTAL CELL RESEARCH

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

(2009) Hiroshi Watanabe et al.   NATURE MEDICINE